NCT05636176

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

TERMINATEDPHASE3INTERVENTIONAL

Trial Details

Start: 2023-05-08Est. Completion: 2026-09-03

Enrollment target: 4,899 participants

Locations

Advanced Cardiovascular, LLC, Alexander City, Alabama, United States
Eastern Shore Rsrch Inst, LLC, Fairhope, Alabama, United States
Heart Center Rsrch_Hunstville, Huntsville, Alabama, United States
Banner University Medical Ctr, Phoenix, Arizona, United States
Cardiology & Medicine Clinic, Little Rock, Arkansas, United States
InvivoCure -2, Alhambra, California, United States
National Heart Institute Cal, Beverly Hills, California, United States
Valley Clinical Trials, Covina, California, United States
Scripps Memorial Hospital La Jolla, La Jolla, California, United States
Purushotham & Akther Kotha MD, inc., La Mesa, California, United States
VA Loma Linda Hlthcr Sys, Loma Linda, California, United States
Biopharma Clinical Research Services, LLC, Los Angeles, California, United States
VA Greater Los Angeles Hlthcare System, Los Angeles, California, United States
VAGrtrLosAngelesHlthcareSystem, Los Angeles, California, United States
Valley Clinical Trials, Inc., Northridge, California, United States

Systemic SclerosisScleroderma

The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus place…

Scottsdale, United StatesEst. completion Jan 6, 2027

Heart Failure

Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety…

Fairhope, United StatesEst. completion Nov 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.